Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. KVK Tech, Inc.
WARNING LETTER
•KVK Tech, Inc.•March 13, 2020

KVK Tech, Inc. – FDA Warning Letter, Mar 13, 2020

Record Details

The FDA issued a Warning Letter to KVK-Tech, Inc. following an inspection from February 4 to March 13, 2020, at their Newtown, PA drug manufacturing facility. The inspection revealed significant violations of current Good Manufacturing Practice (CGMP) regulations, rendering their drug products adulterated under 21 U.S.C. 351(a)(2)(B).

Key violations include: 1. **Failure to establish and follow adequate written procedures for equipment cleaning and maintenance (21 CFR 211.67(b))**: The firm did not validate cleaning processes for non-dedicated packaging equipment (slat counter) as required by their SOP, leading to potential cross-contamination. The FDA found their response inadequate, citing issues with worst-case scenario identification, lack of swab sites in slat cavities, and insufficient explanation for deviating from SOPs. Required actions include improving cleaning validation, identifying worst-case conditions (e.g., drug toxicity, solubility, difficult-to-clean areas), and revising change management for new equipment/products. 2. **Failure to prepare complete batch production and control records (21 CFR 211.188)**: Investigators observed inaccurate air pressure gauge readings recorded in batch records and unrecorded deviations during packaging operations. The firm's response was deemed inadequate for not conducting a comprehensive review of data recording issues or providing a plan for improved management oversight

Company
KVK Tech, Inc.
Inspection date
March 13, 2020
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 02202704-f49a-4279-ad1f-595444e5198c

Violation Codes8
21 CFR 21021 CFR 21121 CFR 211.67(b)21 CFR 211.188FD&C Act 501(a)(2)(B)21 U.S.C. 356C(b)21 CFR 211.3421 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for KVK Tech, Inc.
  • 483 - 2025-03-14March 14, 2025
  • 483 - 2022-07-08July 8, 2022
  • 483 - 2021-06-11June 11, 2021
  • WARNING_LETTER - 2019-04-16April 16, 2019
  • 483 - 2019-04-16April 16, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore KVK Tech, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.